Comparison of [18F]-Tracers in Various Experimental Tumor Models by PET Imaging and Identification of an Early Response Biomarker for the Novel Microtubule Stabilizer Patupilone

被引：0
|
作者：
T. Ebenhan
M. Honer
S. M. Ametamey
P. A. Schubiger
M. Becquet
S. Ferretti
C. Cannet
M. Rausch
P. M. J. McSheehy
机构：
[1] Novartis Institute of Biomedical Research,Global Imaging Group
[2] Eidgenoessische Technische Hochschule (ETH) Zurich,Animal Imaging Center
[3] Novartis Institute of Biomedical Research,PET, Center for Radiopharmaceutical Science
来源：
Molecular Imaging and Biology | 2009年 / 11卷 / 5期
关键词：
D O I：
10.1007/s11307-009-0246-8
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：379 / 380
页数：1
相关论文
共 50 条
  • [1] Comparison of [18F]-Tracers in Various Experimental Tumor Models by PET Imaging and Identification of an Early Response Biomarker for the Novel Microtubule Stabilizer Patupilone
    T. Ebenhan
    M. Honer
    S.M. Ametamey
    P.A. Schubiger
    M. Becquet
    S. Ferretti
    C. Cannet
    M. Rausch
    P.M.J. McSheehy
    Molecular Imaging and Biology, 2009, 11 : 308 - 321
  • [2] Comparison of [18F]-Tracers in Various Experimental Tumor Models by PET Imaging and Identification of an Early Response Biomarker for the Novel Microtubule Stabilizer Patupilone
    Ebenhan, T.
    Honer, M.
    Ametamey, S. M.
    Schubiger, P. A.
    Becquet, M.
    Ferretti, S.
    Cannet, C.
    Rausch, M.
    McSheehy, P. M. J.
    MOLECULAR IMAGING AND BIOLOGY, 2009, 11 (05) : 308 - 321
  • [3] Oncologic PET tracers beyond [18F]FDG and the novel quantitative approaches in PET imaging
    Kumar, R.
    Dhanpathi, H.
    Basu, S.
    Rubello, D.
    Fanti, S.
    Alavi, A.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 52 (01): : 50 - 65
  • [4] Comparison of the [18F]-FDG and [18F]-FLT PET Tracers in the Evaluation of the Preclinical Proton Therapy Response in Hepatocellular Carcinoma
    David Brasse
    Hélène Burckel
    Patrice Marchand
    Marc Rousseau
    Ali Ouadi
    Marie Vanstalle
    Christian Finck
    Patrice Laquerriere
    Frédéric Boisson
    Molecular Imaging and Biology, 2021, 23 : 724 - 732
  • [5] Comparison of the [18F]-FDG and [18F]-FLT PET Tracers in the Evaluation of the Preclinical Proton Therapy Response in Hepatocellular Carcinoma
    Brasse, David
    Burckel, Helene
    Marchand, Patrice
    Rousseau, Marc
    Ouadi, Ali
    Vanstalle, Marie
    Finck, Christian
    Laquerriere, Patrice
    Boisson, Frederic
    MOLECULAR IMAGING AND BIOLOGY, 2021, 23 (05) : 724 - 732
  • [6] Preclinical evaluation of [18F]DiFA, a novel PET probe for tumor hypoxia, in comparison with [18F]MISO
    Yasui, Hironobu
    Zhao, Songji
    Higashikawa, Kei
    Ukon, Naoyuki
    Shimizu, Yoichi
    Matsumoto, Hiroki
    Tamaki, Nagara
    Kuge, Yuji
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [7] [18F]FluorThanatrace PET imaging as a biomarker of response to PARP inhibitors in breast cancer
    Gitto, Sarah B.
    Pantel, Austin R.
    Maxwell, Kara N.
    Pryma, Daniel A.
    Farwell, Michael D.
    Liu, Fang
    Cao, Quy
    O'Brien, Sophia R.
    Clark, Amy S.
    Shah, Payal D.
    Mcdonald, Elizabeth S.
    COMMUNICATIONS MEDICINE, 2025, 5 (01):
  • [8] Preclinical assessment of [18F]-FAHA PET imaging as a novel biomarker for HDAC activity
    Nishii, Ryuichi
    Yeh, Hsin
    Mukhopadhyay, Uday
    Soghomonyan, Suren
    Balatoni, Julius
    Mawlawi, Osama
    Alauddin, Mian
    Higashi, Tatsuya
    Tong, William
    Gelovani, Juri
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [9] [18F]-MNI654 and [18F]-MNI659: novel PET imaging tracers to quantify PDE10A
    Barret, Olivier
    Alagille, David
    Papin, Caroline
    Jennings, Danna
    Waterhouse, Rikki
    McCarthy, Timothy J.
    Russell, David
    Marek, Ken
    Seibyl, John P.
    Tamagnan, Gilles
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2012, 32 : S120 - S120
  • [10] Novel apoptosis imaging biomarker early predicts chemotherapy response in preclinical models: A comparative study with 18F-FDG PET
    Song, Shaoli
    Xiong, Chiyi
    Li, Chun
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
12345